In today’s briefing:
- Aragen Life Science Pre-IPO Tearsheet
- Aequitas: Sembcorp Green Infra Limited Pre-IPO Tearsheet
- Hatsun Agro (HATSUN IN): Record Quarter Masks a Margin Squeeze
- Sembcorp Green Infra Limited (3395333Z IN): Synthetic Expert Call Transcript (04 Sep 2026)
- Sterlite Technologies: Project Lakshya Raises The Stakes
- NSE: SEBI Approves IPO; Valuations Seem Demanding Amid CAS Fracas
- Avaada Electro Limited (2596819D IN): Synthetic Expert Call Transcript (04 Sep 2026)
Aragen Life Science Pre-IPO Tearsheet
- Aragen Life Sciences Limited (ALS IN) is looking to raise at least US$300m in its upcoming India IPO. The deal will be run by Axis, Citi, GS, JM Financial.
- Aragen Life Sciences Limited (ALS) is an India-based, fully integrated contract research, development, and manufacturing organization (CRDMO).
- ALS offers a platform of solutions across the entire drug lifecycle, which spans from contract discovery and preclinical research to contract development and manufacturing for both small molecules and biologics.
Aequitas: Sembcorp Green Infra Limited Pre-IPO Tearsheet
- Sembcorp Green Infra Limited (3395333Z IN) (SGIL) plans to raise around US$393m in its upcoming India IPO. The deal will be run by Axis, Citi, CLSA, HSBC, ICICI, IIFL, Kotak.
- SGIL is a renewable independent power producer (IPP) focused on developing, operating and maintaining utility‑scale and complex renewable projects in India.
- As per CRISIL, it was among the top 10 largest renewable IPPs in India by Operational Capacity as at March 31, 2026.
Hatsun Agro (HATSUN IN): Record Quarter Masks a Margin Squeeze
- Hatsun crossed INR3,000 cr in quarterly revenue for the first time, up 19.3% YOY, but PAT slipped 1.1% as milk cost inflation compressed every margin line.
- We view the topline strength as structurally sound. The profit stall is a cyclical input cost problem, not a demand problem.
- At 60x TTM earnings, Hatsun already prices in a recovery it has yet to deliver.
Sembcorp Green Infra Limited (3395333Z IN): Synthetic Expert Call Transcript (04 Sep 2026)
- Unsigned PPAs/PSAs Gridlock: A massive systemic bottleneck has emerged in the Indian renewable energy market, with a backlog of 40 to 45 GW of awarded capacity stalled due to unsigned Power Purchase Agreements (PPAs) and Power Sale Agreements (PSAs). To resolve this, the Ministry of New and Renewable Energy (MNRE) implemented a major policy shift in early 2026, centralizing all central-level renewable bidding exclusively under the Solar Energy Corporation of India (SECI).
- ISTS Waiver Sunset Pressure: The expiration of the 100% Inter-State Transmission System (ISTS) charges waiver on June 30, 2025, has introduced a phased charges framework (starting at 25% for FY26 and increasing by 25% annually). This phasedown immediately impacts over 26 GW of delayed projects, raising landed tariffs by Rs 0.40 to Rs 0.50 per kWh and forcing developers into long-drawn “Change in Law” petitions at the Central Electricity Regulatory Commission (CERC).
- SGIL’s Deleveraging IPO Strategy: Sembcorp Green Infra Limited’s (SGIL) recent INR 37.50 billion all-primary IPO filing (DRHP dated August 26, 2026) is a targeted balance sheet restructuring play. By allocating INR 30.00 billion to prepay outstanding debt, SGIL will reduce its net debt-to-equity ratio from 1.52x to approximately 0.90x, unlocking debt capacity to fund its 4.04 GW/GWh under-construction pipeline without needing a standalone InvIT.
Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.
Sterlite Technologies: Project Lakshya Raises The Stakes
- Project Lakshya targets Rs. 20,000 crore revenue and more than 27% EBITDA margin by FY29, supported by 50% capacity expansion.
- The plan implies a 61.6% revenue CAGR from FY26 and at least Rs. 5,400 crore of FY29 EBITDA, an earnings reset, if delivered.
- The debate shifts from cyclical fibre recovery to execution, product mix, customer concentration, capex discipline and order conversion.
NSE: SEBI Approves IPO; Valuations Seem Demanding Amid CAS Fracas
- SEBI has approved the draft prospectus of NSE. As per news reports, the management has completed extensive roadshows and is looking to launch the IPO as early as 21st September.
- The new Closing Auction Scheme by SEBI impacts options trading—the NSE’s primary revenue driver.
- Renewed focus on NSE’s dependence on options revenue amid SEBI’s regulatory crackdown is raising concerns that the exchange’s valuation is stretched too high.
Avaada Electro Limited (2596819D IN): Synthetic Expert Call Transcript (04 Sep 2026)
- IPO Valuation Downsizing: Avaada Electro Limited has downsized its proposed IPO from ₹10,000 crore to ₹7,600 crore (consisting of a ₹1,600 crore fresh issue and a ₹6,000 crore offer for sale) due to investor pushback regarding a steep 90% revenue concentration with its sister independent power producer (IPP) entity, Avaada Energy, in FY26.
- Structural Overcapacity and Low Utilization: While India’s solar PV module capacity has reached 233 GW, actual industry-wide factory utilization languishes at 35% to 40% due to a severe domestic shortfall in upstream cell capacity (standing at roughly 27 GW to 30 GW).
- The DCR Premium Arbitrage: Since the domestic content requirement (DCR) cell mandate was enforced on June 1, 2026, DCR modules using local cells command a premium price of ₹21 to ₹24 per watt compared to non-DCR modules (utilizing imported cells) which trade at ₹13 to ₹15 per watt. Avaada’s transition to 3 GW of operational TOPCon cell capacity (with another 3 GW nearing commissioning) positions it to capture this spread, though long-term margins remain highly sensitive to Chinese wafer price volatility.
Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
